Model
Edge
Lineage Cell Therapeutics
0001822933
Filing Type
4
Filing Date
1/1/2024
Updated
1/2/24, 12:08 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership